Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg
July 27, 2019
SABIC CEO says no interest in taking over Clariant
July 28, 2019

LSE’s bid for Refinitiv spotlights quest for data, globality

London Stock Exchange Group Plc’s planned purchase of Refinitiv in a $27 billion deal is the latest sign that exchange operators are focusing more on data products to increase revenue, while also trying to expand their global reach.

Powered by WPeMatico